{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T20:29:37Z","timestamp":1774470577665,"version":"3.50.1"},"reference-count":18,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:p>Included on the World Health Organization Model Lists of Essential Medicines, atropine remains a cornerstone medication that is used for a myriad of clinical indications. Systemically, atropine carries indications for the treatment of asymptomatic and symptomatic bradycardia, reduction of salivation and bronchial secretions prior to surgery, and as an antidote for a variety of poisoning agents (i.e., carbamate or organophosphate insecticides, nerve agents, muscarine-containing mushrooms). Topically, atropine is administered via the ophthalmic route for the treatment of cycloplegia, mydriasis, and amblyopia or may be administered sublingually to treat chronic sialorrhea. As an anticholinergic, supratherapeutic concentrations of atropine result in a toxidrome typical of other anticholinergic medication overdoses. However, it is easy to overlook atropine as the causative agent when being administered topically, potentially resulting in an unnecessarily extensive and complicated workup. This case report describes the systemic absorption of atropine administered through the ophthalmic route at normal doses, resulting in stroke-like symptoms in an adolescent male. Upon identifying that the patient was being treated with atropine ophthalmic drops prior to hospital arrival, a dose of intravenous physostigmine was administered, resulting in complete reversal of all toxidrome symptoms.<\/jats:p>","DOI":"10.5863\/1551-6776-28.6.565","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T17:52:51Z","timestamp":1698688371000},"page":"565-567","source":"Crossref","is-referenced-by-count":2,"title":["Ophthalmic Atropine: A Typical Anticholinergic Toxidrome From an Atypical Old Culprit"],"prefix":"10.5863","volume":"28","author":[{"given":"Michael","family":"Raschka","sequence":"first","affiliation":[{"name":"Department of Pharmacy (MR), Children\u2019s Minnesota, Emergency Department (MK), Children\u2019s Minnesota, Minneapolis, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshal","family":"Khant","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (MR), Children\u2019s Minnesota, Emergency Department (MK), Children\u2019s Minnesota, Minneapolis, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"key":"2023111414184458900_i2331-348X-28-6-565-b1","author":"Atropine sulfate [package insert]","year":"2020"},{"key":"2023111414184458900_i2331-348X-28-6-565-b2","unstructured":"Broderick\n              ED\n            , MethenyH, CrosbyB. Anticholinergic toxicity. In: StatPearls. StatPearls Publishing; 2021. Accessed February 13, 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534798\/"},{"issue":"(4)","key":"2023111414184458900_i2331-348X-28-6-565-b3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.arcped.2013.01.012","article-title":"Systemic adverse effects of topical ocular instillation of atropine in two children [in French","volume":"20","author":"Princelle","year":"2013","journal-title":"]. Arch Pediatr"},{"key":"2023111414184458900_i2331-348X-28-6-565-b4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM196101262640403","article-title":"Toxic effects of atropine and homatropine eyedrops in children","volume":"264","author":"Hoefnagel","year":"1961","journal-title":"N Engl J Med"},{"issue":"(6336)","key":"2023111414184458900_i2331-348X-28-6-565-b5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/bmj.285.6336.196","article-title":"Atropine poisoning in early infancy due to Eumydrin drops","volume":"285","author":"Meerstadt","year":"1982","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"(7)","key":"2023111414184458900_i2331-348X-28-6-565-b6","first-page":"759","article-title":"Letter: Atropine eye-drops delirium","volume":"110","author":"Kounis","year":"1974","journal-title":"Can Med Assoc J"},{"issue":"(2)","key":"2023111414184458900_i2331-348X-28-6-565-b7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S1481803500003821","article-title":"Anticholinergic visual hallucinosis from atropine eye drops","volume":"1","author":"Bishop","year":"1999","journal-title":"CJEM"},{"issue":"(3)","key":"2023111414184458900_i2331-348X-28-6-565-b8","first-page":"342","article-title":"Atropine poisoning with psychosis","volume":"97","author":"Gamboa","year":"1959","journal-title":"AMA J Dis Child"},{"issue":"(5109)","key":"2023111414184458900_i2331-348X-28-6-565-b9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/bmj.2.5109.1390","article-title":"Toxic psychosis following atropine eye-drops","volume":"2","author":"Baker","year":"1958","journal-title":"Br Med J"},{"issue":"(5)","key":"2023111414184458900_i2331-348X-28-6-565-b10","first-page":"450","article-title":"atropine poisoning mimicking acute stroke [in French]","volume":"168","author":"Faivre","year":"2013","journal-title":"Rev Neurol (Paris)"},{"issue":"(1)","key":"2023111414184458900_i2331-348X-28-6-565-b11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5811\/westjem.2011.7.6817","article-title":"Massive atropine eye drop ingestion treated with high-dose physostigmine to avoid intubation","volume":"13","author":"Stellpflug","year":"2012","journal-title":"West J Emerg Med"},{"issue":"(6)","key":"2023111414184458900_i2331-348X-28-6-565-b12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","article-title":"Minimizing systemic absorption of topically administered ophthalmic drugs","volume":"37","author":"Urtti","year":"1993","journal-title":"Surv Ophthalmol"},{"issue":"(6)","key":"2023111414184458900_i2331-348X-28-6-565-b13","first-page":"444","article-title":"Ocular atropine induced psychosis\u2014is there a direct access route to the brain?","volume":"38","author":"Varghese","year":"1990","journal-title":"J Assoc Physicians India"},{"key":"2023111414184458900_i2331-348X-28-6-565-b14","author":"Pred Forte (prednisolone acetate ophthalmic suspension) [package insert].","year":"2020"},{"key":"2023111414184458900_i2331-348X-28-6-565-b15","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: a pharmacokinetic perspective","volume":"10","author":"Farkouh","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"2023111414184458900_i2331-348X-28-6-565-b16","year":"2022"},{"issue":"(4)","key":"2023111414184458900_i2331-348X-28-6-565-b17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0196-0644(00)70057-6","article-title":"A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning","volume":"35","author":"Burns","year":"2000","journal-title":"Ann Emerg Med"},{"issue":"(6)","key":"2023111414184458900_i2331-348X-28-6-565-b18","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jemermed.2018.02.046","article-title":"Physostigmine reversal of dysarthria and delirium after iatrogenic atropine overdose from a dental procedure","volume":"54","author":"Cole","year":"2018","journal-title":"J Emerg Med"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/28\/6\/565\/3288869\/i2331-348x-28-6-565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/28\/6\/565\/3288869\/i2331-348x-28-6-565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:37:57Z","timestamp":1738780677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/28\/6\/article-p565.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10,28]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-28.6.565","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,1]]}}}